These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of steroid hormones and antihormones in cultured cells. Jung-Testas I; Baulieu EE Exp Clin Endocrinol; 1985 Dec; 86(2):151-64. PubMed ID: 2936615 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of glucocorticosteroid action in cultured L-929 mouse fibroblasts by RU 486, a new anti-glucocorticosteroid of high affinity for the glucocorticosteroid receptor. Jung-Testas I; Baulieu EE Exp Cell Res; 1983 Aug; 147(1):177-82. PubMed ID: 6617759 [TBL] [Abstract][Full Text] [Related]
4. Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells. Vignon F; Lippman ME; Nawata H; Derocq D; Rochefort H Cancer Res; 1984 May; 44(5):2084-8. PubMed ID: 6713400 [TBL] [Abstract][Full Text] [Related]
5. Physicochemical and genetic evidence for specific antiestrogen binding sites. Faye JC; Jozan S; Redeuilh G; Baulieu EE; Bayard F Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3158-62. PubMed ID: 6574477 [TBL] [Abstract][Full Text] [Related]
6. Induction of antiproliferation and apoptosis in estrogen receptor negative MDA-231 human breast cancer cells by mifepristone and 4-hydroxytamoxifen combination therapy: a role for TGFbeta1. Liang Y; Hou M; Kallab AM; Barrett JT; El Etreby F; Schoenlein PV Int J Oncol; 2003 Aug; 23(2):369-80. PubMed ID: 12851686 [TBL] [Abstract][Full Text] [Related]
7. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells. Gong Y; Ballejo G; Murphy LC; Murphy LJ Cancer Res; 1992 Apr; 52(7):1704-9. PubMed ID: 1551100 [TBL] [Abstract][Full Text] [Related]
8. Antiestrogens prevent the stimulatory effects of L-triiodothyronine on cell proliferation. Zhou-Li F; Albaladejo V; Joly-Pharaboz MO; Nicolas B; Andre J Endocrinology; 1992 Mar; 130(3):1145-52. PubMed ID: 1537281 [TBL] [Abstract][Full Text] [Related]
9. A naturally occurring estrogen receptor mutation results in increased estrogenicity of a tamoxifen analog. Catherino WH; Wolf DM; Jordan VC Mol Endocrinol; 1995 Aug; 9(8):1053-63. PubMed ID: 7476979 [TBL] [Abstract][Full Text] [Related]
10. Accumulation of a non-binding form of estrogen receptor in MCF-7 cells under hydroxytamoxifen treatment. Leclercq G; Legros N; Piccart MJ J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):545-52. PubMed ID: 1562525 [TBL] [Abstract][Full Text] [Related]
11. Interaction of DP-TAT-59, an active metabolite of new triphenylethylene-derivative (TAT-59), with estrogen receptors. Toko T; Matsuo K; Shibata J; Wierzba K; Nukatsuka M; Takeda S; Yamada Y; Asao T; Hirose T; Sato B J Steroid Biochem Mol Biol; 1992 Nov; 43(6):507-14. PubMed ID: 1419885 [TBL] [Abstract][Full Text] [Related]
12. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells. Katzenellenbogen BS; Norman MJ; Eckert RL; Peltz SW; Mangel WF Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799 [TBL] [Abstract][Full Text] [Related]
13. Comparative study on the induction of cytostasis and apoptosis by ICI 182,780 and tamoxifen in an estrogen receptor-negative ovarian cancer cell line. Ercoli A; Scambia G; Fattorossi A; Raspaglio G; Battaglia A; Cicchillitti L; Malorni W; Rainaldi G; Benedetti Panici P; Mancuso S Int J Cancer; 1998 Mar; 76(1):47-54. PubMed ID: 9533761 [TBL] [Abstract][Full Text] [Related]
14. Chick oviduct glucocorticosteroid receptor. Specific binding of the synthetic steroid RU 486 and immunological studies with antibodies to chick oviduct progesterone receptor. Groyer A; Le Bouc Y; Joab I; Radanyi C; Renoir JM; Robel P; Baulieu EE Eur J Biochem; 1985 Jun; 149(2):445-51. PubMed ID: 3996417 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of estrogen receptor, antiestrogen binding sites and calmodulin for antiestrogen resistance of two clones derived from the MCF-7 breast cancer cell line. Borras M; Jin L; Bouhoute A; Legros N; Leclercq G Biochem Pharmacol; 1994 Nov; 48(11):2015-24. PubMed ID: 7802690 [TBL] [Abstract][Full Text] [Related]
16. Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth. Coezy E; Borgna JL; Rochefort H Cancer Res; 1982 Jan; 42(1):317-23. PubMed ID: 7053859 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen. Attardi B; Happe HK Endocrinology; 1986 Aug; 119(2):904-15. PubMed ID: 3732150 [TBL] [Abstract][Full Text] [Related]
18. Regulation of estrogen and progestin receptor concentrations in an experimental rat prostatic carcinoma by estrogen, antiestrogen, and progesterone. Mobbs BG; Johnson IE; DeSombre ER; Toth J; Hughes A Cancer Res; 1987 May; 47(10):2645-51. PubMed ID: 3552202 [TBL] [Abstract][Full Text] [Related]
19. Autocrine regulation of cell proliferation by estradiol and hydroxytamoxifen of transformed mouse Leydig cells in serum-free culture. Nishizawa Y; Sato B; Miyashita Y; Tsukada S; Hirose T; Kishimoto S; Matsumoto K Endocrinology; 1988 Jan; 122(1):227-35. PubMed ID: 3275537 [TBL] [Abstract][Full Text] [Related]